FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma

Clin Nucl Med. 2022 Jun 1;47(6):e452-e454. doi: 10.1097/RLU.0000000000004144. Epub 2022 Mar 30.

Abstract

A 52-year-old woman with a rapidly growing uterine tumor suspected of uterine sarcoma underwent 18F-FDG PET/MRI, revealing a myometrial mass and an endometrial lesion, suggesting dual primary neoplasms. Based on the PET/MRI findings, we changed the intraoperative procedure to determine the necessity of pelvic lymphadenectomy. PET/MRI was useful in diagnosing and differentiating between 2 malignant neoplasms in the uterus compared with PET/CT, due to MRI's high contrast resolution and precise fusion due to the simultaneous acquisition.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma* / diagnostic imaging
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Leiomyosarcoma* / diagnostic imaging
  • Magnetic Resonance Imaging
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals
  • Uterine Neoplasms* / diagnostic imaging

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18